ESR1 and breast cancer: In particular, rG4-mediated translational elongation stalling was found to affect the proteolysis of the human estrogen receptor [63] and estrogen receptor signaling is a key regulator of cell proliferation, differentiation, and survival in hormone-sensitive cancers, including breast cancer [64].